Open Payments

ENRIQUE A. FLORES

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology
Where
Covington, GA
NPI
1134170517
Received
$40,784 in 48 records, 2019 to 2025
As principal investigator
$206,132 of research payments to others in 225 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment9$191
2024General payment6$129
2023General payment1$16
2022General payment9$227
2021General payment6$119
2020General payment2$27
2019General payment15$40,072

By company

CompanyRecordsAmountYears
Merit Medical Systems Inc7$39,2502019
Terumo Medical Corporation6$7852019
E.R. Squibb & Sons, L.L.C.4$902024–2025
AstraZeneca Pharmaceuticals LP5$852019–2022
Janssen Pharmaceuticals, Inc3$752021–2022
Abbott Laboratories3$682022–2024
Actelion Pharmaceuticals US, Inc.3$552024–2025
Teleflex LLC1$552022
ABIOMED2$542022
Surmodics, Inc.3$482023–2025
Medtronic, Inc.3$482021–2024
Novartis Pharmaceuticals Corporation2$432022–2025
HEARTFLOW, INC.1$372025
Amgen Inc.2$322020–2025
Edwards Lifesciences Corporation1$272024
Chiesi USA, Inc.1$142019
Merck Sharp & Dohme LLC1$122021

By nature of payment

NatureRecordsAmount
Consulting Fee7$39,250
Food and Beverage37$865
Travel and Lodging3$623
Education1$45

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-18Amgen Inc.$18Food and BeverageIn-kind items and servicesREPATHA Biological, Cardiovascular2025
2025-11-06E.R. Squibb & Sons, L.L.C.$25Food and BeverageCash or cash equivalentCAMZYOS Drug, Cardiovascular2025
2025-09-11Novartis Pharmaceuticals Corporation$18Food and BeverageIn-kind items and servicesLEQVIO Drug, Cardiology/Vascular Diseases2025
2025-09-03Surmodics, Inc.$16Food and BeverageCash or cash equivalentPounce Thrombectomy Device, Pounce Arterial Packaged Assembly, Sterile2025
2025-08-28HEARTFLOW, INC.$37Food and BeverageCash or cash equivalentFFRct Device, Coronary2025
2025-08-14E.R. Squibb & Sons, L.L.C.$17Food and BeverageCash or cash equivalentCAMZYOS Drug, Cardiovascular2025
2025-06-12E.R. Squibb & Sons, L.L.C.$23Food and BeverageCash or cash equivalentCAMZYOS Drug, Cardiovascular2025
2025-03-26Surmodics, Inc.$15Food and BeverageCash or cash equivalentPounce Thrombectomy Device, Pounce Arterial Packaged Assembly, Sterile2025
2025-02-13Actelion Pharmaceuticals US, Inc.$18Food and BeverageIn-kind items and servicesOPSUMIT Drug, Cardiology2025
2024-11-13Abbott Laboratories$25Food and BeverageIn-kind items and servicesCARDIOMEMS Device, Heart Failure2024
2024-10-11Medtronic, Inc.$14Food and BeverageIn-kind items and servicesONYX FRONTIER Device, Stents2024
2024-10-10Actelion Pharmaceuticals US, Inc.$21Food and BeverageIn-kind items and servicesUPTRAVI Drug, Cardiology2024
2024-09-05Actelion Pharmaceuticals US, Inc.$16Food and BeverageIn-kind items and servicesOPSUMIT Drug, Cardiology2024
2024-08-22E.R. Squibb & Sons, L.L.C.$23Food and BeverageCash or cash equivalentCAMZYOS Drug, Cardiovascular2024
2024-02-20Edwards Lifesciences Corporation$27Food and BeverageIn-kind items and servicesEdwards SAPIEN 3 Ultra Transcatheter Heart Valve Device, Transcatheter Heart Valves2024
2023-11-13Surmodics, Inc.$16Food and BeverageCash or cash equivalentSublime 014 Rx PTA Balloon Dilatation Catheter Device, Peripheral angioplasty balloon catheter2023
2022-12-01Novartis Pharmaceuticals Corporation$24Food and BeverageIn-kind items and servicesLEQVIO Drug, CARDIOVASCULAR2022
2022-11-10AstraZeneca Pharmaceuticals LP$16Food and BeverageIn-kind items and servicesFARXIGA Drug, Cardiovascular and Metabolism2022
2022-09-28AstraZeneca Pharmaceuticals LP$19Food and BeverageIn-kind items and servicesFARXIGA Drug, Cardiovascular and Metabolism2022
2022-08-09Abbott Laboratories$20Food and BeverageIn-kind items and servicesHeartMate Touch Device, Heart Failure2022
2022-07-20Janssen Pharmaceuticals, Inc$14Food and BeverageIn-kind items and servicesXARELTO Drug, Cardiovascular & Metabolism2022
2022-06-29Teleflex LLC$55Food and BeverageIn-kind items and servicesMANTA Device, Interventional Access2022
2022-03-15ABIOMED$26Food and BeverageIn-kind items and servicesImpella Device, Cardiology/Vascular Diseases2022
2022-03-03Abbott Laboratories$22Food and BeverageIn-kind items and servicesHeartMate Touch Device, Heart Failure2022
2022-02-22ABIOMED$28Food and BeverageIn-kind items and servicesImpella Device, Cardiology/Vascular Diseases2022
2021-12-10Janssen Pharmaceuticals, Inc$45EducationIn-kind items and servicesXARELTO Drug, Cardiovascular & Metabolism2021
2021-08-26Merck Sharp & Dohme LLC$12Food and BeverageIn-kind items and servicesVERQUVO Drug, CARDIOVASCULAR2021
2021-08-11Janssen Pharmaceuticals, Inc$14Food and BeverageIn-kind items and servicesXARELTO Drug, Cardiovascular & Metabolism2021
2021-07-27AstraZeneca Pharmaceuticals LP$13Food and BeverageIn-kind items and servicesFARXIGA Drug, Cardiovascular and Metabolism2021
2021-03-24Medtronic, Inc.$17Food and BeverageIn-kind items and servicesHawkOne Device, Directional Atherectomy Devices2021
2021-02-03Medtronic, Inc.$15Food and BeverageIn-kind items and servicesResolute Device, Stents2021
2020-12-10Amgen Inc.$13Food and BeverageIn-kind items and servicesRepatha Biological, Cardiology2020
2020-02-10AstraZeneca Pharmaceuticals LP$13Food and BeverageIn-kind items and servicesFARXIGA Drug, Cardiovascular and Metabolism2020
2019-08-31Merit Medical Systems Inc$6,800Consulting FeeCash or cash equivalent2019
2019-08-31Merit Medical Systems Inc$3,500Consulting FeeCash or cash equivalent2019
2019-07-26Terumo Medical Corporation$196Travel and LodgingCash or cash equivalentNavicross Device, Vascular Access2019
2019-07-26Terumo Medical Corporation$19Food and BeverageCash or cash equivalentNavicross Device, Vascular Access2019
2019-07-26Terumo Medical Corporation$14Food and BeverageCash or cash equivalentGlidesheath Device, Lesion Access2019
2019-07-25Terumo Medical Corporation$129Food and BeverageCash or cash equivalentNavicross Device, Vascular Access2019
2019-07-25Terumo Medical Corporation$79Travel and LodgingCash or cash equivalentNavicross Device, Vascular Access2019
2019-07-16Merit Medical Systems Inc$6,550Consulting FeeCash or cash equivalent2019
2019-06-07Terumo Medical Corporation$346Travel and LodgingCash or cash equivalentNavicross Device, Vascular Access2019
2019-05-25Merit Medical Systems Inc$7,800Consulting FeeCash or cash equivalent2019
2019-05-25Merit Medical Systems Inc$7,300Consulting FeeCash or cash equivalent2019
2019-04-18Chiesi USA, Inc.$14Food and BeverageCash or cash equivalentKENGREAL Drug, CARDIOVASCULAR2019
2019-03-30Merit Medical Systems Inc$2,500Consulting FeeCash or cash equivalent2019
2019-03-09Merit Medical Systems Inc$4,800Consulting FeeCash or cash equivalent2019
2019-03-03AstraZeneca Pharmaceuticals LP$22Food and BeverageIn-kind items and servicesBRILINTA Drug, Cardiovascular and Metabolism2019

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2023-05-10Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$28,287A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2023
2022-12-31Merck Sharp & Dohme LLCGEORGIA HEART SPECIALISTS, LLC COVINGTON$450A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center pivotal phase III clinical out2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-08-18Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$32A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-07-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$32A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-06-17Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$1,204A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-05-23Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-04-22Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-04-22Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-04-22Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$32A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-04-22Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-04-22Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$389A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$389A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-21Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-03-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2022-01-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2022
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$32A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-16Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$389A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-12-01Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-10-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-10-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-10-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$663A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021
2021-10-25Esperion Therapeutics, Inc.GEORGIA HEART SPECIALISTS LLC$244A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Newton CountyCovington city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Covington, GA, county Newton County, GA, state Georgia; placed by its city name.

MeasurePlace (city or town)
Covington, GA
County
Newton County, GA
State
Georgia
Population B0100314,584118,15210,940,407
Population, 2020 census P114,192112,48310,711,908
Median age B0100237.836.837.6
Under 18 B0100125.1%25.3%23.2%
65 and over B0100116.8%13.4%15.0%
Households B110015,66241,2034,074,366
Foreign born B050026.2%7.0%11.2%
Median household income B19013$58,810$77,179$77,353
Median family income B19113$72,262$88,631$93,754
Per capita income B19301$32,109$33,172$40,924
Poverty rate B1700120.4%12.3%13.4%
Unemployment rate B230257.3%6.6%5.1%
Civilian labor force B230257,09859,2345,496,061
Mean commute (minutes) B0801336.535.928.3
Bachelor's degree or higher B1500327.2%25.0%34.9%
Housing units B250016,21743,6194,541,835
Owner-occupied B2500348.6%73.8%65.7%
Renters B2500351.4%26.2%34.3%
Median home value B25077$301,900$265,000$303,300
Median gross rent B25064$1,191$1,439$1,393
White, not Hispanic B0300239.3%38.8%49.1%
Black B0300249.1%47.3%30.7%
Hispanic or Latino B030027.9%7.1%11.0%
Asian B030020.4%1.5%4.5%
American Indian and Alaska Native B030020.0%0.1%0.1%

Economy now FRED unemployment 3.3% in Sep 2026 (3.4% a year earlier); per capita personal income $65,111 in 2025, up 26% in five years (+1.6% after inflation); Unemployment rate: 5.4% in Sep 2016 to 3.3% in Sep 2026; low 3.0%, high 12.5% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Covington, GA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.